The antibiotic paenimucillin A was originally identified using a cultureindependent synthetic-bioinformatic natural product (syn-BNP) discovery approach. Here we report on a bioinformatics-guided survey of paenimucillin A analogs that led to the discovery of paenimucillin C. Paenimucillin C inhibits the growth of multidrug-resistant (MDR) Acinetobacter baumannii clinical isolates, as well as other Gram-negative bacterial pathogens. In a rat cutaneous wound model, it completely sterilized MDR A. baumannii wound infections with no sign of rebound. Mechanistic studies point to a membrane-associated mode of action that results in leakage of intracellular contents.
|Original language||English (US)|
|State||Published - Jan 1 2018|
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Acinetobacter baumannii
- Wound infections